The Infectious Diseases Society of America aimed to develop up-to-date guidance focusing on the treatment of antimicrobial-resistant gram-negative infections.
Typically, the first-line treatment for a potentially life-threatening infection would be to administer intravenous (IV) broad-spectrum antibiotics, such as piperacillin-tazobactam. Then, once the ...